Saltar al contenido
Merck

Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells.

STAR protocols (2020-12-31)
Veronika Sander, Aneta Przepiorski, Amanda E Crunk, Neil A Hukriede, Teresa M Holm, Alan J Davidson
RESUMEN

Kidney organoids represent a physiologically advanced model for studying the mechanisms of kidney development and disease. Here, we describe a simple two-step protocol for the differentiation of human pluripotent stem cells into kidney organoids. Our approach involves suspension culture that allows for rapid and cost-effective bulk production of organoids, which is well suited for large-scale assays such as drug screening. The organoids correspond to fetal human kidney tissue and may be of limited use for modeling adult kidney function. For complete details on the use and execution of this protocol, please refer to Przepiorski et al. (2018).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ácido clorhídrico, ACS reagent, 37%
Sigma-Aldrich
Xilenos, histological grade
Sigma-Aldrich
Citrato de sodio tribásico dihydrate, ≥99%, FG
Sigma-Aldrich
Cloruro de sodio, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
Poli(vinil alcohol), 87-90% hydrolyzed, average mol wt 30,000-70,000